This age disparity shows that while ALT elevation is associated with similar metabolic risk factors such as diabetes, hypertension and dyslipidaemia, it is an imperfect surrogate marker for MAFLD as it may under recognise MAFLD in older patients and additional diagnostic methods are often required17,32,33. This evidence concerns the gene GPT and Hypertension.